New Merck study results raise questions about its COVID-19 pill

New study results disclosed by Merck & Co. on Friday indicated its COVID-19 pill molnupiravir may not be as effective as the company previously stated, a finding that could change how the Food and Drug Administration and its advisers view the drug at an upcoming meeting.